Can-Fite BioPharma Ltd. CANF
1.58 USD -0.02 (-1.25%)
Nov 6, 2026, 10:03 AM EST
1.57 Day range 1.66
1.50 52-week range 12.40
- YTD
- -60.50%
- 1 year
- -81.19%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 405.00K | 674.00K | 743.00K | 810.00K | 853.00K | |
| 405.00K | 674.00K | 743.00K | 810.00K | 853.00K | |
| -9.95M | -8.13M | -8.20M | -10.10M | -12.84M | |
| -9.83M | -7.88M | -7.63M | -10.17M | -12.62M | |
| -11.94 | -21.72 | -35.84 | -60.00 | -180.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 5.53M | 4.83M | 4.28M | 2.98M | 4.39M | |
| 9.51M | 9.12M | 9.99M | 9.28M | 20.25M | |
| 3.92M | 3.68M | 3.75M | 4.81M | 5.87M | |
| 71.00K | 104.00K | 40.00K | 62.00K | 124.00K | |
| 5.59M | 5.44M | 6.24M | 4.47M | 14.38M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -8.95M | -7.64M | -8.44M | -10.80M | -9.86M | |
| -2.00K | 1.50M | 498.00K | 9.50M | -14.51M | |
| 9.64M | 6.71M | 9.14M | 0 | 20.46M | |
| -2.00K | -5.00K | -2.00K | -9.00K | -11.00K | |
| 703.00K | 547.00K | 1.30M | -1.41M | -3.88M |